Previous Close | 43.84 |
Open | 44.36 |
Bid | 37.72 x 1000 |
Ask | 44.30 x 1100 |
Day's Range | 42.83 - 45.07 |
52 Week Range | 31.36 - 46.62 |
Volume | |
Avg. Volume | 961,624 |
Market Cap | 6.114B |
Beta (5Y Monthly) | 1.24 |
PE Ratio (TTM) | 14.78 |
EPS (TTM) | 3.00 |
Earnings Date | Aug 08, 2022 - Aug 12, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 48.57 |
Subscribe to Yahoo Finance Plus to view Fair Value for HALO
Endo (ENDP) plunges on reports of negotiations with its lenders and senior bondholders about a possible restructuring of more than $8 billion of debt.
We provide five reasons, which make Halozyme (HALO) a good investment option in 2022.
Community Health (CYH) employs PeriGen's technology to bring about enhanced obstetrics services and assure the safety of mothers as well as babies in the labor and delivery procedures.